CN Bio introduced its PhysioMimix™ ‘in-a-box’ reagent kit for Non-alcoholic steatohepatitis (NASH). The company designed its in-a-box reagent kit to overcome the growing prevalence of NASH. In conjunction with CN Bio’s PhysioMimix MPS, the kit provides researchers with in-house capabilities to gain physiologically relevant insights into the mechanism of disease, human drug efficacy, and safety toxicology. In addition, the company claims the assay addresses the human-relevance limitations of existing approaches, bridging the gap between human 2D cell culture and expensive animal models, which are ineffective in mimicking the entire disease spectrum.